团体与个体哀伤聚焦认知行为治疗对老年人之随机临床试验
这项非劣效随机临床试验纳入113名65岁及以上、有临床相关延长哀伤障碍(PGD)等症状的丧亲老年人,比较团体与个体哀伤聚焦认知行为治疗(GF-CBT)。结果显示团体GF-CBT在6个月随访时对PGD症状的疗效非劣于个体GF-CBT,且所有次要结局均支持非劣效性。
要点
- 团体GF-CBT在6个月随访时对PGD症状非劣于个体GF-CBT(d=0.09;95%CI,-0.06至0.25)。
- 两种格式均随时间大幅降低PGD症状(团体d=1.74;个体d=1.46)。
- 脱落率团体23%对个体19%,团体GF-CBT可作为老年人丧亲后可行的治疗格式。
核心结论
- 在6个月随访时,团体GF-CBT在减少老年PGD症状方面非劣于个体GF-CBT,且对PTSD、抑郁和焦虑症状也显示非劣效性。
- 两种治疗格式随时间对症状均有较大效应,似为有PGD及其他丧亲后障碍症状老年人的相关治疗格式。
研究设计与样本
- 非劣效随机临床试验,2021年4月至2025年5月入组并收集数据,在自然临床实践中招募与治疗,按1:1随机分配至团体GF-CBT或个体GF-CBT,随访至治疗后6个月。
- 纳入65岁及以上、基于自评问卷既定临界值存在临床相关水平PGD、PTSD、抑郁和/或焦虑的丧亲老年人,共113人(平均[SD]年龄71.58[5.86]岁;女性92人[81.4%],男性20人[17.7%],性别信息缺失1人[.09%]),团体GF-CBT组56人、个体GF-CBT组57人。
- 两种干预均为12次每周会话(团体每次2小时,个体每次1小时),包含相同顺序的干预技术(暴露、认知重构和行为激活)。
主要发现
- 意向性治疗样本的混合线性模型显示,两种格式随时间对PGD症状均有统计学显著的大幅下降(团体GF-CBT:d=1.74;个体GF-CBT:d=1.46)。
- 6个月随访时团体GF-CBT对比个体GF-CBT的d=0.09(95%CI,-0.06至0.25),达到非劣效。
- 所有次要结局均支持团体GF-CBT的非劣效性;脱落率为团体23%对个体19%。
关键数值与推荐
- 主要结局为用延长哀伤-13问卷测量的PGD症状,在治疗前、治疗后、3个月随访和6个月随访(主要终点)测量。
- 次要结局包括PTSD、抑郁、焦虑、孤独感、社会支持、功能损害、生活质量和幸福感症状。
- 非劣效性判定依据6个月随访时团体与个体GF-CBT比较的d=0.09(95%CI,-0.06至0.25)。
临床怎么用
- 对于有临床相关PGD及丧亲后PTSD、抑郁和/或焦虑症状的65岁及以上老年人,团体GF-CBT可作为个体GF-CBT的非劣效替代格式。
- 团体格式每次2小时、个体格式每次1小时,均每周1次共12次,采用暴露、认知重构和行为激活技术。
- 选择格式时可结合资源与患者偏好考虑团体GF-CBT,同时注意团体脱落率23%略高于个体19%。
局限性
- 原文未报告盲法、样本量计算依据及非劣效界值设定等细节。
- 研究在自然临床实践中开展,参与者基于自评问卷临界值纳入,可能影响外推性。
- 随访至治疗后6个月,缺乏更长期疗效数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Grief-focused cognitive behavioral therapies (GF-CBTs) are found effective in treating prolonged grief disorder (PGD), but the relative efficacy of different delivery formats is unknown. While evidence for individual GF-CBT (GF-CBT individual) is well established, evidence for group GF-CBT (GF-CBT group) is scarce. However, the group format holds possible advantages in a bereavement context. OBJECTIVE: To examine whether GF-CBT group is noninferior to GF-CBT individual in reducing PGD symptoms in older adults. DESIGN, SETTING, AND PARTICIPANTS: Enrollment and data collection for this noninferiority randomized clinical trial took place from April 2021 to May 2025. Participants were randomized 1:1 to GF-CBT group and GF-CBT individual and followed up with until 6 months posttreatment. Recruitment and treatment were done in a naturalistic clinical practice. Participants included older bereaved adults (65 years or older) with clinically relevant levels of PGD, posttraumatic stress disorder (PTSD), depression, and/or anxiety based on established cutoffs on self-report questionnaires. These data were analyzed from June 2025 through August 2025. INTERVENTIONS: GF-CBT group and GF-CBT individual consisted of 12 weekly sessions (duration: 2 hours vs 1 hour), including the same intervention techniques in the same order (exposure, cognitive restructuring, and behavioral activation). MAIN OUTCOMES AND MEASURES: Outcomes were measured at pretreatment, posttreatment, 3-month follow-up, and 6-month follow-up as the primary end point. The primary outcome was PGD symptoms measured with the Prolonged Grief-13 questionnaire. Secondary outcomes included symptoms of PTSD, depression, anxiety, loneliness, social support, functional impairment, quality of life, and well-being. RESULTS: Participants (N = 113; mean [SD] age, 71.58 [5.86] years; 92 female [81.4%], 20 male [17.7%], and 1 person [.09%] had missing information on gender) were randomized to GF-CBT group (n = 56) or GF-CBT individual (n = 57). Mixed linear models on the intention-to-treat sample showed that both formats yielded statistically significant large reductions in PGD symptoms over time (GF-CBT group: d = 1.74; GF-CBT individual: d = 1.46). GF-CBT group was noninferior compared with GF-CBT individual (d = 0.09; 95% CI, -0.06 to 0.25) at 6-month follow-up. The noninferiority of GF-CBT group was evidenced for all secondary outcomes. Dropout rates were 23% (GF-CBT group) vs 19% (GF-CBT individual). CONCLUSIONS AND RELEVANCE: In this study, GF-CBT group was noninferior to GF-CBT individual at 6-month follow-up in reducing PGD symptoms, but also symptoms of PTSD, depression, and anxiety. Both formats had large effects on symptoms over time and appear to be relevant treatment formats for older adults with symptoms of PGD and other disorders post loss. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT04694807.
引用
- Komischke K, Boelen PA, Maccallum F, et al. Group Vs Individual Grief-Focused Cognitive Behavioral Therapy for Older Adults: A Randomized Clinical Trial. JAMA Psychiatry. 2026. PMID: 41533372. doi:10.1001/jamapsychiatry.2025.4106
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。